DONATE
GET INVOLVED
Clinical Trial Finder
Observational Closed to Enrollment
GI symptoms observational study (GALAXY) (GALAXY-OB-18)
This study will collect information on gastrointestinal (GI) symptoms that people with CF experience.
This study will require a single visit where participants will enroll in the study and take four questionnaires. Participants will take these questionnaires at three different times outside the clinic. Researchers will evaluate the results to learn about CF GI symptoms and treatment.
Study Design
-
Study Type: ?more info
Observational -
Randomized Study: ?more info
No -
Placebo Controlled: ?more info
No -
Length of Participation:
29 days -
Number of Study Visits:
1
Additional Information
-
Phase: ?more info
Not Applicable -
Study Sponsor: ?more info
-
Study Drugs:
N/A
Study Sites
-
Closed to Enrollment
California
Stanford University Medical Center, Palo Alto, CA 94304
-
Closed to Enrollment
Connecticut
Central Connecticut Cystic Fibrosis Center, Hartford, CT 06106
-
Closed to Enrollment
District of Columbia
Children's National Medical Center, Washington, DC 20010
-
Closed to Enrollment
Florida
All Children's Hospital, St. Petersburg, FL 33701
-
Closed to Enrollment
Florida
Nemours Children's Clinic - Pensacola, Pensacola, FL 32514
-
Closed to Enrollment
Georgia
Children’s Healthcare of Atlanta and Emory University, Atlanta, GA 30322
-
Closed to Enrollment
Illinois
OSF HealthCare Children’s Hospital of Illinois, Saint Francis Medical Center, Peoria, IL 61637
-
Closed to Enrollment
Illinois
Northwestern University, Chicago, IL 60611
-
Closed to Enrollment
Indiana
Riley Hospital for Children, Indianapolis, IN 46202
-
Closed to Enrollment
Kentucky
University of Kentucky, Lexington, KY 40506
-
Closed to Enrollment
Maine
Maine Medical Center, Portland, ME 04102
-
Closed to Enrollment
Massachusetts
University of Massachusetts Memorial Health Care, Worcester, MA 01655
-
Closed to Enrollment
Massachusetts
Boston Children's Hospital, Brigham & Women's Hospital, Boston, MA 02115
-
Closed to Enrollment
Michigan
Helen DeVos Children's Hospital, Grand Rapids, MI 49503
-
Closed to Enrollment
Minnesota
The Minnesota Cystic Fibrosis Center, Minneapolis, MN 55455
-
Closed to Enrollment
Missouri
SSM Health Cardinal Glennon Children’s Hospital, St. Louis, MO 63104
-
Closed to Enrollment
New Jersey
Rutgers - Robert Wood Johnson Medical School, New Brunswick, NJ 08903
-
Closed to Enrollment
North Carolina
Wake Forest University Baptist Medical Center, Winston-Salem, NC 27103
-
Closed to Enrollment
North Carolina
Atrium Health Pulmonary Care, Charlotte, NC 28203
-
Closed to Enrollment
Ohio
Nationwide Children's Hospital, Columbus, OH 43205
-
Closed to Enrollment
Oklahoma
Oklahoma Cystic Fibrosis Center, OKC, OK 73104
-
Closed to Enrollment
Oregon
Oregon Health Sciences University, Portland, OR 97239
-
Closed to Enrollment
Pennsylvania
Children's Hospital of Philadelphia, Philadelphia, PA 19104
-
Closed to Enrollment
Texas
University of Texas Southwestern / Children’s Health, Dallas, TX 75247
-
Closed to Enrollment
Utah
Primary Children's Cystic Fibrosis Center, Salt Lake City, UT 84113
-
Closed to Enrollment
Vermont
University of Vermont Medical Center, Burlington, VT 05401
Related Topics
-
Questions to Ask When Considering a Specific Trial
Clinical trials that test potential drugs and therapies in people with cystic fibrosis are a major part of CF research. They take place at Cystic Fibrosis Foundation-accredited care centers all over the United States and enroll people with CF of all ages.
-
Patient Safety Is a Priority
Nothing is more important than patient safety in developing new treatments for cystic fibrosis. The U.S. government requires that all clinical trials are supervised for safety, and the Cystic Fibrosis Foundation adds additional measures to protect study volunteers.
-
Trikafta™
The following is a collection of information and news about Trikafta™, the triple-combination modulator therapy that was approved by the U.S. Food and Drug Administration on Oct. 21, 2019.
